Maffucci syndrome Q78.42

Author: Prof. Dr. med. Peter Altmeyer

Last updated on: 15.05.2024

Synonym(s)

Chondrodysplasia Hemangioma Syndrome; Enchondromatosis type II; hemangiomatous dyschondroplasia; Kashch's syndrome; Kast's syndrome; Maffucci-Kast Syndrome; Maffucci's Syndromes; OMIM 166000

History
This section has been translated automatically.

Angelo Maffucci, 1881

Definition
This section has been translated automatically.

Maffucci syndrome (MS, OMIM 166000) is an extremely uncommon, non-hereditary, multisystemic disorder characterized by multiple enchondromas and vascular lesions, most of which are spindle cell hemangiomas.

You might also be interested in

Dermatology

Fibrosarcoma

Very rare, malignant connective tissue tumour, usually originating from tendons or fasciae (rarely primaril...

Advertisment

Etiopathogenesis
This section has been translated automatically.

Unknown. There are vascular malformations associated with enchondromas and an increased risk of sarcoma. Post-zygotic mutations of the genes for isocitrate dehydrogenase(IDH1 or IDH2 gene) have been detected (Sun Y et al. 2022).

Manifestation
This section has been translated automatically.

> 75% of cases manifest themselves before puberty, 25% already in the first year of life.

Clinical features
This section has been translated automatically.

Multiple enchondromas predominantly on the hands and feet (70-80%), less frequently on the long tubular bones (40-60%), ribs, pelvis and shoulder blades (20-30%), rarely on vertebral bodies, skull, clavicles and sternum (2-10%). Multiple capillary or cavernous hemangiomas of the skin and internal organs. Secondary deformation and shortening of the affected skeletal parts, short stature, often with asymmetrical shortening of the legs.

Diagnosis
This section has been translated automatically.

Clinical, radiological.

Differential diagnosis
This section has been translated automatically.

If other benign tumours and tissue hyperplasia are present at the same time, a Proteus syndrome should be considered.

Complication(s)
This section has been translated automatically.

Malignant degeneration of tumors in about 23% of published patients (chondrosarcomas, hemangiosarcomas, lymphangiosarcomas, fibrosarcomas, gliomas, etc.).

Therapy
This section has been translated automatically.

The focus is on monitoring patients for the development of sarcomas, especially chondrosarcomas (30%), but also angiosarcomas, fibrosarcomas and osteosarcomas. Sarcomatically altered tissue is removed surgically. Correction of bone deformities and fractures by the orthopaedist. Monitoring and treatment of hemangiomas by the dermatologist. The disease usually comes to a halt in the second decade of life.

Progression/forecast
This section has been translated automatically.

In 20% inclination to develop malignant tumours; inclination to bone fractures, see also Ollier's syndrome.

Literature
This section has been translated automatically.

Holzmann H et al. (1994) Chondrodysplasia-hemangioma syndrome (Maffucci's syndrome) 20: 292-295
Kaplan RP et al (1993) Maffucci's syndrome: two case reports with a literature review. J Am Acad Dermatol 29: 894-899
Lewis RJ, Ketcham AS (1973) Maffucci's syndrome: functional and neoplastic significance. J Bone Jt Surg 55-A: 1465-1479
Maffucci A (1881) Di un caso encendroma ed angioma multiple. Movimento medico-chirurgico (Napoli) 3: 399-412, 565-575
Moore BA et al. (2003) Maffucci's syndrome and cartilaginous neoplasms of the trachea. Otolaryngol Head Neck Surg 128: 583-586
Sun Y et al. (2022) Cell-free DNA from plasma as a promising alternative for detection of gene mutations in patients with Maffucci syndrome. Hereditas 59:4.